lower motor disorders
TRANSCRIPT
NOTE:
To change
the image
on this
slide,
select the
picture
and delete
it. Then
click the
Pictures
icon in the
placeholde
r to insert
your own
image.
Amr Hassan, M.D. Associate professor of Neurology - Cairo University
LOWER MOTOR
DISORDERS
3/9/2017 2
1. The anterior (ventral) horn cell 2. The radicle (root).
3. The peripheral nerve. 4. The neuromuscular junction. 5. The muscle.
5
4
2
1
2
2
3
Motor Neurone diseases
Disorders of the AHC Motor Neurone Diseases (MNDs)
Definition:
• A group of purely motor degenerative
disorders that involve selective loss of the
function of upper and/or lower motor
neurons innervating the voluntary
musculature of the limb and bulbar regions.
Motor Neurone Diseases (MNDs)
Classification : • Combined LMN and UMN involovement
Amyotrophic lateral sclerosis
• Pure UMN involovement
Primary lateral sclerosis
Hereditary spastic paraplegia
• Pure LMN involovement =Spinal muscular atrophy (SMA)
Acute infantile SMA (Werdnig-Hoffmann syndrome).
Bulbo-SMA (Kennedy's syndrome).
Chronic childhood SMA (Kugelberg-Welander syndrome).
Distal SMA.
MND
UMNL
primary
Lateral sclerosis
Hereditary spastic
paraplegia
LMNL
Acute infantile SMA (Werdnig-
Hoffmann syndrome
Bulbo-SMA (Kennedy's syndrome
Chronic childhood
SMA (Kugelberg-Welander
syndrome).
Distal
SMA.
COMBINED
Amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis
Pure UMNL Pure LMNL
Bulbar (cranial
nerves)
Pseudo bulbar
palsy
True bulbar palsy
Limbs Spastic
quadriplegia
Progressive muscular
atrophy
Pseudo bulbar palsy True bulbar palsy
Bulbar symptoms: Dysphagia,dysarthria,
hoarseness of voice
recurrent choking attacks.
Dysphagia,dysarthria,
hoarseness of voice,
nasal tone of voice,
nasal regurgitation.
Platal and pharyngeal reflex Exaggerated Lost
Emotional lability Commonly present Absent
Jaw reflex Exaggerated Normal
Amyotrophic lateral sclerosis
Definition:
• Motor degenerative disorders that involve selective loss of the function of upper and lower motor neurons.
Pathogenesis:
• Oxidative stress theory: Disruption of cell detoxification mechanismsoxidative stress on neurons neuronal degeneration.
• Loss of certain neurotrphic factors: These factors are responsible for maintenance and survival of neurons.
Amyotrophic lateral sclerosis
• Lou Gehrig was a Major League Baseball player who played first base for the New York Yankees from 1923-1939. Gehrig set the records for most grand slams in a season and most consecutive games played. Gehrig was stricken with amyotrophic lateral sclerosis, now commonly known as Lou Gehrig's disease.
Amyotrophic lateral sclerosis
Clinical picture: ALS has gradual onset and progressive course.
Cranial nerves examination:
• Oculomotor nerves: are usually spared
• Pseudobulbar palsy
Amyotrophic lateral sclerosis
Motor system examination: Weakness both U.L.s and L.L.s, usually starts at U.L.
Weakness of neck muscles chin drop.
= Tonic Atrophy
Combined features of UMNL and LMNL: UMNL: +ve Babinski sign, hyperreflexia.
N.B. Sensory system examination: Normal (as purely motor disorder)
LMNL:wasting(D>P), fasiculations (tongue &bulky muscle).
Amyotrophic lateral sclerosis
Diagnosis: can be made on clinical bases.
Electrophysiological studies:
• Nerve conduction studies are also required to exclude motor neuropathy & to provide evidence of chronic denervation.
Neuroimaging studies: to exclude conditions which may cause UMN and/or LMN signs that may simulate ALS e.g. focal quadriparesis due to cervical cause.
Amyotrophic lateral sclerosis
Treatment: A) Non -Pharmacological:
Speech therapy. d) Physiotherapy.
Nutritional support. e) Occupational therapy.
Respiratory therapy. f) Mental health care.
B) Pharmacological:
1. Symptomatic treatment: e.g. muscle relaxant for treatment of stiffness.
2. Potentially disease modifying drugs:
Glutamate antagonists: Riluzole: 50-200 mg / d.
Antioxidant drugs : e.g. Vitamin E.
Neurotrphic factors: e.g. Nerve growth factor.
Other lines of treatment:e.g. Stem cell therapy, gene therapy.
3/9/2017 20
1. The anterior (ventral) horn cell 2. The radicle (root).
3. The peripheral nerve. 4. The neuromuscular junction. 5. The muscle.
5
4
2
1
2
2
3
II. Disorders of The Spinal Roots (Radiculopathies)
Intervertebral Disc and Its Disorders
• The intervertebral disc = central gelatinous
part, "the nucleus pulposus," surrounded by a
fibrous tissue ring, "the annulus fibrosus" and
covered from above and below by a
cartilaginous plate.
Intervertebral Disc and Its Disorders
Acute disc prolapse:
• There is sudden rupture of the annulus fibrosis followed by bulging (herniation) of the nucleus pulposus; this compresses the spinal roots.
• It may occur at any age and usually follows trauma, as lifting heavy objects or jumping to the floor from a height.
Intervertebral Disc and Its Disorders
B) Spondylosis: • Definition:
It is the gradual, progressive degeneration of the intervertebral discs, specially those which are freely mobile as they are more subjected to the process of wear and tear. The freely mobile discs are mainly found in the cervical and lumbar regions.
Intervertebral Disc and Its Disorders
B) Spondylosis: • Predisposing factors: Old age and excessive mobility of the
spine as in labourers.
• Pathology:
• In spondylosis, there is degeneration of the annulus fibrosus, leading to herniation of the nucleus pulposus with subsequent compression of adjacent structures. As the weakest parts of the annulus fibrosus are the lateral and posterior parts, the herniation will be either lateral, posterior or posterolateral.
Acute disc prolapse Lumbar spondylosis
Age Any age Middle and old age
Cause Traumatic Degenerative
Onset Acute Gradual
X-ray Narrowed intervertebral space. Narrowed intervertebral space sclerosis,
lipping & osteophytes.
Selected Radiculopathies Cauda Equina
Cauda Equina
Causes of cauda equina lesions: • Congenital: Spinabifida.
• Traumatic:
• Fracture or fracture dislocation of
• the lumbar vertebrae.
• Post traumatic disc prolapse.
• Inflammatory: Pott's disease of the
• lumbar vertebrae.
• Neoplastic.
• Degenerative: lumbar spondylosis.
Cauda Equina
Clinical picture of cauda equina lesions:
Motor manifestations:
L.M.N.
Cauda Equina Root Action Muscles
L2 Flexor of the hip Ileopsoas.
L3 Extensor of the knee Quadriceps
L4 Dorsiflexion of the ankle Anterior tibial group
L5 Dorsiflexion of the toes Anterior tibial group & glutei
S1 Plantar flexion of the ankle and toes Calf muscles & glutei
S2 Flexor of the knee Hamstrings
S3, 4, 5 Anal contraction Anal and perianal muscles
Cauda Equina
Sensory manifestations:
• The sensory impairment affects both
superficial and deep sensations. Initially
irritative lesion radicular pain destructive
lesion hyposthesia or anaesthesia in the
dermatome supplied by the affected root.
Cauda Equina Root Sensory
L1 Upper third of the front of the thigh.
L2 Middle third of the front of the thigh
L3 Lower third of the front of the thigh.
L4 Antero-lateral aspect of the thigh, Front of the knee, of the knee , Antero - Medial
aspect of the leg, medial aspect of the dorsum of the foot and the foot and big toe.
L5 Lateral aspect of the thigh and leg, Middle third of the dorsum of the foot and
Middle three toes.
S1 Postero-lateral aspect of the thigh and leg, Lateral third and little toe .
S2 Posterior aspect of the thigh and leg and sole of the foot.
S 3,4, 5 Anal, perianal and gluteal region (saddle-shaped area).
Cauda Equina
Autonomic manifestations:
• Sphincteric manifestations are usually late unless the lesion is bilateral and affects mainly S2,S3,S4 roots (roots of innervation of the bladder). The Sphincteric disturbances are in the form of: sensory atonic bladder,Motor atonic bladder or Autonomic bladder.
• Vasomotor changes and trophic ulcers may occur in the L.L.
Cauda Equina
Investigations: 1) Plain X-ray:
Narrowing of the intervertebral disc spaces.
Sclerosis of the adjacent surfaces of the vertebrae.
Lipping or osteophytic formations due to calcification of the prolapsed parts and ligaments
Straightening of the spines (loss of lordosis).
2) M.R.I
can visualize the intervertebral discs, degree of disc herniation, vertebrae, the facet joints, the nerves, and the ligaments in the spine and can reliably diagnose nerve compression.
Cauda Equina
Treatment:
There is no treatment to reverse the process of spondylosis, because it is a degenerative process.
The treatments of spondylosis target the back pain and neck pain.Available treatments fall into several categories:
General measures:
• Bed rest prolongs the time to recovery. Therefore, it is recommended to continue normal or near normal activities. However, do not do anything that could exacerbate the problem, such as heavy lifting.
• Some people find heat and/or ice to be helpful for back and neck pain caused by spondylosis.
Cauda Equina
Medical: Analgesics &muscle relaxants.
Physiotherapy.
Adjunctive therapies.
Chiropractic spinal manipulation may be helpful to some people, especially within the first month of pain.
Acupuncture.
Injections and Minimally Invasive Procedures for Spondylosis:Steroids (cortisone) can be injected into the epidural space (the space surrounding the spinal cord). This is known as an epidural injection.
Cauda Equina
Surgical: Surgery is rarely necessary in patients with acute back pain, unless progressive neurologic problems develop,surgical interference is indicated in cases of:
1. Severe intolerable pain.
2. Bladder disturbances (in cases of cervical spondylosis), denoting severe cord compression.
3. Motor weakness.
4. Marked Sensory deficit.
Conus lesion Epiconus lesion
Anatomically lowermost three segments of the
spinal cord S3,S4,S5
L4,L5,S1,S2
Motor affection No motor disability in L.Ls Weakness or paralysis in L.Ls, in the
muscles supplied by L4S2. revise
table. )
Sensory affection No sensory loss in the lower limbs.
- ↓ sensations in saddle-shaped
area.
↓ sensations from L4 to S2 segment.
Sphincteric
affection
Early urinary incontinence
(autonomic bladder) and faecal
incontinence.
- Impotence.
Precipitancy may occur
B.Sciatica
Definition: It is radicular pain along the distribution of the sciatic nerve (L4,5,S1,2,3) i.e. along the back of the thigh, leg and foot.
The most common causes of sciatica are:
• Acute disc prolapse.
• Lumbar spondylosis.
B.Sciatica Spinal canal at the
lumbosacral regions
Intervertebral
foramina
Pelvis Sciatic nerve
- Acute lumbar disc
prolapse.
- Fracture dislocation.
- Lumbar spondylosis.
- Pott's disease or
tumours.
- Neurofibroma
- Ankylosing
spondylitis.
- Radiculitis.
Compression of
sciatic plexus over
the sacro-iliac joint
by:
- Malignant
tumours of the
bladder,rectum..
- Pelvic abscess.
- Pregnant
retroverted
uterus.
- Neuritis as diabetic,
alcoholic and
rheumatic.
- Pressure on the nerve
by dislocated head of
femur.
- Wrong injection into
the nerve.
B.Sciatica
Clinical picture of sciatica:
• Sensory manifestations: Pain and paraesthesias along the course of the sciatic nerve, aggravated by walking which stretches the nerve and also by coughing, straining or sneezing. Tenderness on direct pressure on the sciatic nerve.
• Motor: Slight L.M.N. weakness in the muscles supplied by the nerve The paravertebral muscles may be spastic; resulting in loss of lumbar lordosis.
• Signs of meningeal irritation: +ve Kernig, Lassegue & Brudzinski signs.
B.Sciatica
• Investigations: M.R.I. lumbosacral spine
• Treatment: Treatment of the cause.
C. Cervical Spondylosis
It may present by one of the 3 following manifestations
depending on the direction of prolapse of the disc.
1. Manifestations of root compression (lateral prolapse):
a) Ventral root compression: There is motor weakness or paralysis in one or both lower limbs of a L.M.N. nature involving the muscles which are supplied by the affected root. The function of each root can be easily tested in the following muscles:
C. Cervical Spondylosis
Root Action Muscle
C l,2 Lateral movement of neck Sternomastoid & trapezius
C 3.4 Elevation of shoulder Supra and infraspinatus
C5 Abduction of shoulder Deltoid
C 5,6 Flexion of elbow Biceps & brachioradialis
C 6,7 Extension of elbow Triceps
C 7.8 Extension of wrist Extensors of wrist
C 8,T 1 Flexion of wrist & movement of small ms of
hands
Flexors of wrist
C. Cervical Spondylosis
• Posterior root compression:The sensory impairment
affects both superficial and deep sensations. Initially
irritative lesion radicular pain destructive
lesion hyposthesia or anaesthesia in the
dermatome supplied by the affected root.
Root Sensory distribution
C2 Lateral aspect of neck
C3,4 Shoulder down to manubrium anteriorly
C5 Lateral aspect of arm
C6 Lateral aspect of forearm, thenar eminence & thumb
C7 Middle aspect of forearm, middle of palm, middle 3 fingers
C8 Medial aspect of forearm, hypothenar eminence & little finger
T1 Medial aspect of arm
C. Cervical Spondylosis
2. Manifestations of cord compression (Posteroir
prolapse):
This results in weakness or paralysis with signs of U.M.N.L.
3. Manifestations of root and cord compression (Postero–lateral prolapse):
Combined features of UMNL and LMNL: In the lower limbs ,UMNL: +ve Babinski sign, hyperreflexia.
In the upper limb ,LMNL:wasting(D>P), fasiculations
(tongue &bulky muscle).
D.Brachial Neuralgia
Definition: It is radicular pain along the distribution of the brachial plexus (C5 —> Tl) i.e. in the shoulder and U.L.
Causes:
• It may be due to:
• Cervical spondylosis and disc prolapse.
• Cervical rib.
• Brachial neuritis: a mononeuritis multiplex of acute onset due to infection or post-vaccine.
• Referred pain from the heart (angina, myocardial infarction), or gallbladder.
D.Brachial Neuralgia
Clinical picture:
• Sensory manifestations: Pain and paraesthesias along the course of the brachial plexus.
• Motor: Slight L.M.N. weakness in the muscles supplied by the the brachial plexus.
Investigations:
• M.R.I. cervical spine and EMG and NC study.
Treatment: Treatment of the cause.
3/9/2017 62
1. The anterior (ventral) horn cell 2. The radicle (root).
3. The peripheral nerve. 4. The neuromuscular junction. 5. The muscle.
5
4
2
1
2
2
3
III. Diorders of the peripheral nerves Peripheral Neuropathy
Definition:
• It is inflammation or degeneration of the peripheral nerves and/or the cranial nerves resulting in impairment of the conductivity of these nerves leading to motor, sensory and autonomic manifestations.
Classification of peripheral nerves
• There are three types of peripheral nerves:
Motor
Sensory
Autonomic.
Classification of peripheral neuropathies
1. Mononeuropathy: affecting a single nerve trunk in one limb.
2. Mononeuropathy multiplex: affecting more than one nerve trunk in one limb.
3. Polyneuropathy: systemic affection of the peripheral nerves of all limbs.
Classification of peripheral neuropathies
Acute , Chronic ,
Subacute,
intermittent
Axonal vs
demyelinating Sensory vs motor
Inherited vs
acquired
Peripheral neuropathy
Peripheral Neuropathy
Causes of Mononeuropathy (DVTI):
• Diabetes mellitus.
• Vascular: polyarteritis nodosa.
• Trauma: wrong injection into a nerve, callus compression.
• Infective: leprosy, herpes zoster.
Peripheral Neuropathy
Causes of polyneuropathy: • Amyloidosis
• Paraneoplastic syndromes: bronchial carcinoma, lymphoma, myeloma
• Collagen vascular disorders: e.g. rheumatoid arthritis, polyarteritis nodosa, scleroderma and systemic lupus erythematosis.
• Drugs and toxins: e.g. I.N.H, cycloserine, sulphonamides, corticoids, phenytoin, vincristine.
• Diabetes mellitus.
• Deficiency disorders: e.g. beri beri, pellagra, S.C.D.
• Endocrinal causes: acromegaly, myxoedema
• Organ Failure: liver and renal failure
• Granulomatous e.g. sarcoidosis.
• Heridofamilial:
• Infection:
– Viral: acute post-infective poiyneuritis, mumps, measles.
– Bacterial: diphtheria, typhus, typhoid, tetanus.
– Mycobacterial: leprosy.
• Immune mediated: Landry-Guillain-Barre syndrome (acute post-infective polyneuropathy).
• Idiopathic.
Peripheral Neuropathy
Clinical picture of polyneuropathy:
A. Motor:
• Weakness or paralysis of L.M.N. nature (wasting, hypotonia, hyporeflexia . . .).
• The weakness and wasting are:
• Bilateral and symmetrical.
• Affecting L.L. > U.L.
• Affecting distal muscles > proximal muscles.
• Affecting extensors > flexors, so weakness in the extensors of the distal group of muscles leads to bilateral foot drop and wrist drop.
Peripheral Neuropathy
Clinical picture of polyneuropathy:
Sensory:
• Irritative lesion: distal pain and paraesthesia in the limbs.
• Destructive lesion:
• Superficial sensory impairment of the stock and glove distribution.
• Deep sensory loss specially distally with absence of deep reflexes sensory ataxia.
Autonomic:
• Vasomotor: coldness and cyanosis of the limbs.
• Cutaneous: loss of hair, brittle nails, trophic ulcers.
Positive Symptoms
Negative Symptoms
Somatic Nerves
Sensory Pain Numbness
Tingling Lack of feeling
Motor Cramps Weakness
Fasciculations Atrophy
Autonomic Nerves
Hyperhydrosis Orthostatic hypotension
Diarrhea Impotence
Anhydrosis
Constipation
Table 4. Positive and Negative Symptoms Associated with Nerve Damage
Diabetic Polyneuropathy
Diabetes mellitus is the most common cause of neuropathy worldwide.
• Length-dependent Diabetic Polyneuropathy
More than 80% of patients with clinical diabetic neuropathy have a distal symmetrical form of the disorder.
Peripheral Neuropathy
Selected polyneuropathies
Diabetic Neuropathy
Pathogenesis
Diabetic microangiopathy of the vasa nervosa ischaemia of the nerves, 2ry to atherosclerosis of the vasa nervosa.
Peripheral Neuropathy
Diabetic Neuropathy
Clinical picture:
Sensory manifestations:
• The polyneuropathy is mainly sensory.
• In early diabetes or in the pre-diabetic stage, the neuropathy is of the mononeuritic type which may affect the sciatic, femoral, lateral popliteal, ulnar or median nerves or Cr. III, VI or VII nerves Then the neuropathy is of the polyneuritic type.
Peripheral Neuropathy
Diabetic Neuropathy Autonomic manifestations: e.g. impotence, sensory, motor or
autonomic bladder, postural hypotension, gastroparesis, ,hyperhydrosis or anhydrosis, trophic skin changes(ulcers, loss of hair, brittle nails) and Charcot's neuropathic joint.
Motor manifestations:weakness may occur late in the disease.
Treatment:
1. Proper management of diabetes: diet, oral hypoglycaemic drugs or insulin.
2. Drugs for treatment of neuropathic pain.
Peripheral Neuropathy
Acute Infective Polyneuritis
Landry-Guillain-Barre Syndrome
Aetiology:
It is due to an allergic or auto-immune reaction secondary to a previous non-specific virus infection.
Peripheral Neuropathy
Acute Infective Polyneuritis
Landry-Guillain-Barre Syndrome
Clinical Picture:
• Febrile stage: it starts with an influenza-like attack with fever, headache, malaise, pains all over the body with no nervous symptoms.
• Latent stage: the above symptoms disappear and the patient is free for 1-4 weeks.
Peripheral Neuropathy
Acute Infective Polyneuritis
Landry-Guillain-Barre Syndrome Paralytic stage:
• There is acute severe weakness or paralysis starting in the L.L. and ascending to involve the trunk and respiratory muscles, followed by the U.L. muscles.
• Weakness is proximal more than distal.
• Sensory impairment may occur.
• Early in the disease there is tenderness of the calves.
• The cranial nerves are usually involved specially Cr. VII and X resulting in bilateral facial paralysis and bulbar symptoms.
Peripheral Neuropathy
Chronic Immune Demyelinating Polyneuropathy (CIDP)
Epidemiology: Male > Female: 2:1
Clinical picture: Motor affection > Sensory affection
– Onset: Slowly progressive, relapsing-remitting course
– Motor system:
– Weakness: Proximal > Distal ,Symmetric.
– Tendon reflexes: Reduced or absent.
– Sensory system: • All modalities are affected.
– Cranial nerves: • Ocasional, mild, symmetric weakness of VII, X, XII.
Peripheral Neuropathy
Chronic Immune Demyelinating Polyneuropathy (CIDP)
Investigations:
– Electrophysiology: Conduction block and demyelinating neuropathy.
– Nerve biopsy: Onion bulbs in peripheral nerve.
Treatment: Steroids, I.V. immune globulin, plasma exchange and immunosuppressant drugs.
Hereditary motor sensory neuropathy (Charcot Marie Tooth)
• Charcot–Marie–Tooth neuropathy is a
genetically and clinically heterogeneous group of inherited disorders of the peripheral nervous system
Hereditary motor sensory neuropathy (Charcot Marie Tooth)
• It has a gradual onset and a very slow, progressive course.
• The wasting and weakness start in the lower limbs in the peronii muscles then the anterior tibial group, then ascend to involve the muscles of the lower 1/3 of the thigh resulting in the inverted champagne - bottle appearance.
• In spite of the marked degree of wasting there is mild disturbance of motor power (i.e. discrepancy between the degree of wasting and the degree of motor weakness).
• Sensations are impaired specially the vibration sense which is markedly diminished.
• Skeletal deformities are usually present e.g., pes cavus, scoliosis.
• It was classified from groups I to VII:
Hereditary motor sensory neuropathy (Charcot Marie Tooth)
Type Other names
HMSN1 Charcot–Marie–Tooth disease type 1
HMSN2 Charcot–Marie–Tooth disease type 2
HMSN3 Dejerine–Sottas disease
HMSN4 Refsum disease
HMSN5 Charcot–Marie–Tooth disease with pyramidal features
HMSN6 Charcot–Marie–Tooth disease with optic atrophy
HMSN7 HMSN + retinitis pigmentosa
3/9/2017 88
1. The anterior (ventral) horn cell 2. The radicle (root).
3. The peripheral nerve. 4. The neuromuscular junction. 5. The muscle.
5
4
2
1
2
2
3
NMJ Disorders
II. Disorders of The Neuromuscular Junction
Myasthenia Gravis
Definition
An autoimmune disorder that affects acetylcholine receptors interfering with neuromuscular transmission causing easy fatigability of skeletal muscles.
Immunopathogenesis
• Normally thymus gland is the site where T lymphocytes mature.
• Thymic dysfunction abnormal auto-reactive T cells activation of B cells production of autoantibodies directed to the acetylcholine receptors on the postsynaptic side of the neuromuscular junction in skeletal muscles impairment of the neuromuscular transmission.
Clinical features
• Diurnal variation
• Descending order ↓
• Easy fatigability
• More common in Females
Clinical features
Cranial nerve affection
• Ocular muscles are affected first in 40% of patients and eventually in 85%.
• Ptosis and diplopia are common presentations.
• Bilateral LMN facial weakness.
• True bulbar palsy dysarthria, dysphagia, nasal tone of voice and nasal regurgitation of fluids.
Clinical features
Respiratory muscle weakness:
may cause respiratory failure in severe cases
Motor system:
The disease gradually progress to involve more skeletal muscles, usually in a descending order limb weakness proximal > distal.
Sensory system:
Sensations are normal (MG is a neuro MUSCULAR disorder).
Diagnosis
Clinical testing :
• Neostigmine test: mix 0.6mg of atropine sulfate with 1.5 -2.5mg of neostigmine in a 3 cc syringe , change is usually apparent within 15 min. and is most obvious 30 min following injection.
• Fatigability tests: repetition of a given action, such as maintaining upward deviation of the eyes for testing for the eyelidsappearance of ptosis
Diagnosis
Acetylcholine receptors antibodies: 85-90% of generalized cases and 50% of ocular cases.
Electromyography:
• Neuromuscular transmission studies may show a decremental response in the amplitude of the muscle action potential with repetitive nerve stimulation at 3 Hz. A decrement of more than 10% when comparing the fifth to the first response is positive.
• Single-fiber electromyography.
CT chest with contrast: to exclude thymoma.
Treatment
• Anticholinesterases
• Corticosteroids.
• Plasmapheresis.
• IVIG.
• Thymectomy.
Prognosis
• If untreated may end in respiratory failure and death.
• Spontaneous remission may occur, usually after several years.
The myasthenic crisis
• Myasthenic crisis occurs when weakness from acquired myasthenia gravis becomes severe enough to necessitate intubation for ventilatory support or airway protection.
Triggers:
• Infections e.g. upper respiratory tract infection.
• Physical stress (such as trauma or a surgical procedure, including thymectomy).
• Changes in medications e.g. recent initiation or tapering of corticosteroid dosage.
• In 30% to 40% of crises, no obvious trigger can be identified.
Management:
• ICU admission and supportive care.
• Removing triggers.
• Plasma exchange.
The myasthenic crisis
Triggers:
• Infections e.g. upper respiratory tract infection.
• Physical stress (such as trauma or a surgical procedure, including thymectomy).
• Changes in medications e.g. recent initiation or tapering of corticosteroid dosage.
• In 30% to 40% of crises, no obvious trigger can be identified.
Management:
• ICU admission and supportive care.
• Removing triggers.
• Plasma exchange.
3/9/2017 118
1. The anterior (ventral) horn cell . 2. The peripheral nerve. 3. The neuromuscular junction. 4. The muscle.
Muscle diseases
V. Disorders of The Muscles Mypopathy
• Causes of myopathy
• Primary Myopathies:
– Muscular dystrophies (MD):
X-linked AD AR
Duchenne
(DMD)
Becker
(BMD)
Limb girdle MD;
Facioscapulohum
eral (FSH)
Myotonia
dystrophica
Oculophayngeal
MD.
Distal MD.
V. Disorders of The Muscles Mypopathy
• Congenital myopathies: Myotubular (Centronuclear) Myopathy; Nemaline Myopathy; Central Core Disease.
• Metabolic/Enzyme deficiency:Phosphorylase deficiency (MCardle), Acid maltase deficiency (Pompe), Phosphofructokinase deficiency (Tarui), Debrancher enzyme deficiency (Cori Forbes) and mitochondrial myopathy.
V. Disorders of The Muscles Mypopathy
Secondary Myopathies – Infectious: e.g. trichinosis; cysticercosis; toxoplasmosis;
Lyme disease; Staph aureus pyomyositis; human immunodeficiency virus (HIV); coxsackie A and B viruses; influenza.
– Toxic/Metabolic: e.g. alcohol, several medicines (corticosteroids; AZT; statins; colchicine; amiodarone; cocaine).
– Endocrinal: Corticosteroids (Addison or Cushing), hyper or hypothyroidism, hyperparathyroidism.
– Inflammatory: Polymyositis, dermatomyositis, inclusion body myositis.
Duchenne Muscular Dystrophy (DMD)
Definition:
• Is a recessive X-linked form of muscular dystrophy, affecting around 1 in 3,600 boys, which results in muscle degeneration and weakness.
V. Disorders of The Muscles Mypopathy
• Congenital myopathies: Myotubular (Centronuclear) Myopathy; Nemaline Myopathy; Central Core Disease.
• Metabolic/Enzyme deficiency:Phosphorylase deficiency (MCardle), Acid maltase deficiency (Pompe), Phosphofructokinase deficiency (Tarui), Debrancher enzyme deficiency (Cori Forbes) and mitochondrial myopathy.
Duchenne Muscular Dystrophy (DMD)
Definition:
• Is a recessive X-linked form of muscular dystrophy, affecting around 1 in 3,600 boys, which results in muscle degeneration and weakness.
Duchenne Muscular Dystrophy (DMD)
• Genetics: • The disorder is caused by a mutation in the dystrophin gene,
located on the human X chromosome, which codes for the protein dystrophin, an important structural component within muscle tissue.
• Since women have two X chromosomes, if one X chromosome has the non-working gene, the second X chromosome will have a working copy of the gene to compensate. Because of this ability to compensate, women rarely develop symptoms. Males have only one X chromosome, so one copy of the mutated gene will cause DMD.
Duchenne Muscular Dystrophy (DMD)
Clinical picture:
• Usually appear in male children < 5 years and may be visible in early infancy.
• Progressive proximal muscle weakness of the legs and pelvis associated with a loss of muscle mass is observed first inability to climb the stairs then weakness spreads to the arms, neck, and other areas, low endurance, and difficulties in standing unaided or inability to ascend staircases.
Duchenne Muscular Dystrophy (DMD)
Clinical picture: • The weakness is of L.M.N. nature i.e. it is associated with
wasting, hypotonia, hyporeflexia. The weakness and wasting are bilateral, symmetrical and proximal more than distal i.e., the shoulder and arm are more affected than the forearm and hand and the hip and thigh are more affected than the leg and foot.
• Pseudohypertrophy develops as the condition progresses, muscle tissue experiences wasting and is eventually replaced by fat and fibrotic tissue (fibrosis). Pseudo hypertrophy affect mainly the gluteus maximus, quadriceps and calf muscles in the L.L., and the deltoid, supra and infra spinatus muscles in the U.L.
Duchenne Muscular Dystrophy (DMD)
Clinical picture: The weakness and wasting of the shoulder, pelvic girdle and trunk muscles
results in:
• a) Winging of the scapulae due to weakness of the serratus anterior and trapezius.
• b) Pot-belly abdomen due to weakness of the abdominal muscles.
• c) Exaggerated lumbar lordosis due to weakness of the extensor muscles of the trunk in an attempt from the patient, to prevent himself from falling forwards by the effect of gravity.
• d) Waddling gait due to weakness of the gluteus medius & minimus (abductors of the hip).
• e) Characteristic manner in getting up from the floor (climbing test or Gower's sign) due to weakness of the gluteus maximus.
Duchenne Muscular Dystrophy (DMD)
Clinical picture:
• There is selectivity of the involved muscles e.g., there is atrophy of the sternal head of the pectoralis major with preservation of its clavicular head.
• Later on there are fibrosis and contractures of the affected muscles resulting in skeletal deformities e.g. pes cavus and talipes equinus.
• No mentality changes, sensory changes or sphincteric disturbances.
Gower sign
Duchenne Muscular Dystrophy (DMD)
Complications:
• Deformities (particularly kyphosis).
• Permanent, progressive disability manifested as decreased mobility or decreased ability to care for self.
• Cardiomyopathy.
• Pneumonia or other respiratory infections.
• Respiratory failure.
Duchenne Muscular Dystrophy (DMD)
Investigations: • Creatine phospho kinase (CPK-MM) levels in the bloodstream
are extremely high.
• An electromyography (EMG): small MUP, polyphasesity, early recruitement which denote muscle disease.
• DNA testing : DNA testing confirms the diagnosis in most cases.
• A muscle biopsy confirms the absence of dystrophin, although improvements in genetic testing often make this unnecessary.
• E.C.G. changes, histological changes in the heart due to associated cardiomyopathy.
• Prenatal tests: via Chorion villus sampling (CVS) ,Amniocentesis or Fetal blood sampling.
Duchenne Muscular Dystrophy (DMD)
Treatment:
• There is no current cure for DMD.
• Treatment is generally aimed at controlling the onset of symptoms to maximize the quality of life e.g. corticosteroids such as prednisolone and deflazacort.
• Physical therapy is helpful to maintain muscle strength, flexibility, and function. Orthopedic appliances (such as braces and wheelchairs) may improve mobility and the ability for self-care.
• Appropriate respiratory support.
Duchenne Muscular Dystrophy (DMD)
Prognosis:
• Duchenne muscular dystrophy is a progressive disease which eventually affects all voluntary muscles and involves the heart and breathing muscles in later stages. The life expectancy is currently estimated to be around 25.
Becker muscular dystrophy (BMD)
Definition:
• Is a recessive X-linked form of muscular dystrophy affecting around 3 to 6 in 100,000 male births which results in muscle degeneration and weakness.
Genetics:
• Becker muscular dystrophy is related to Duchenne muscular dystrophy in that both result from a mutation in the dystrophin gene, but in Duchenne muscular dystrophy no functional dystrophin is produced making DMD much more severe than BMD.
Becker muscular dystrophy (BMD)
Duchenne MD Becker MD
Age of onset 1st decade 2nd and 3rd decades
Dystrophin Absent Deficient
Severity of the
condition
Severe Less severe
Course Progressive Slowly progressive
Skeletal deformities Present Absent
E.C.G. changes Commonly present Absent
Facioscapulohumeral muscular dystrophy
• AD
• Initially affects the skeletal muscles of the face (facio), scapula (scapulo) and upper arms (humeral).
• it is widely stated to be the third most common genetic disease of skeletal muscle.
• Symptoms may develop in early childhood and are usually noticeable in the teenage years.
Facioscapulohumeral muscular dystrophy
• A progressive skeletal muscle weakness usually develops in other areas of the body as well; often the weakness is asymmetrical.
• Life expectancy is normal, but up to 15% of affected individuals become severely disabled and eventually must use a wheel chair.
Facioscapulohumeral muscular dystrophy
Limb-girdle muscular dystrophy
• This is a heterogeneous group of conditions that usually appear in adolescence or adult life with proximal limb weakness. The weakness usually progresses slowly, but it may arrest spontaneously.
• There are at least 15 different mutations that contribute to LGMD
• Some of them are AR,others are AD.
Myotonic Dystrophy
Definition of myotonia: Delayed relaxation of the skeletal muscles after voluntary, mechanical or electrical stimulation.
– Voluntary: when the patient voluntarily clenches his fist, he is unable to open his hand, except after sometime.
– Mechanical:on tapping the thenar eminence, adduction of the thumb occurs with difficulty & delay in abduction.
– Electrical: 2-3 milliamperes are sufficient to produce contraction of the muscle due to hyperexcitability.
The myotonic phenomenon: Improves by: repetition of movement, warmth, calcium, quinine, procamamide and worsened by: cold, potassium and prostigmine.
Myotonic Dystrophy
• Myotonic dystrophy is an AD condition, usually begins in childhood or young adult life.
• Myotonic dystrophy, as opposed to most forms of myopathy, is characterized by distal weakness, affecting the muscles of the hands before more proximal musculature.
• In addition, facial (muscles of mastication) and neck musculature are involved early.
• Numerous non-neurologic problems are found: frontal balding, testicular atrophy, diabetes, cardiac arrhythmias, and others. It progresses slowly.
Myositis Polymyositis
• Definition: It is an acquired autoimmune disease of the skeletal muscle.
• Clinical Picture:
• Age: usually above 30 years, unless there is an associated collagen disorder.
Myositis Polymyositis
• Onset: acute or subacute with general symptoms of fatigue followed by:
• Pain and tenderness of the muscles (60% of cases).
• Weakness affecting: – The proximal muscles of U.L. and L.L.
– The posterior neck muscles (forward lolling of the head).
– The pharyngeal and laryngeal muscles (bulbar symptoms).
• No involvement of the ocular muscles.
• The deep reflexes are intact.
Dermatomyositis In this disease the clinical picture of polymyositis is
associated with cutaneous manifestations as Gottron papules on dorsum of hand and heliotropic rash on upper eyelid.
Investigations:
1. labs: ↑ E.S.R, ↑↑C.P.K. in serum.
2. E.M.G. shows a myopathic pattern with fibrillation potentials.
Treatment:
1. Steroids.
2. Immunosuppressive drugs.
159 3/9/2017